Application 215430

Type
NDA
Sponsor
AXSOME THERAPEUTICS, INC.

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AUVELITYDEXTROMETHORPHAN HYDROBROMIDE AND BUPROPION HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL45MG/105MGNoNo
002AUVELITYBUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDETABLET, EXTENDED RELEASE;ORAL105MG;30MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
81968-045AUVELITYdextromethorphan hydrobromide, bupropion hydrochlorideAxsome Therapeutics, Inc.NDACurrent
81968-045AUVELITYdextromethorphan hydrobromide, bupropion hydrochlorideAxsome Therapeutics, Inc.NDACurrent
81968-045AUVELITYdextromethorphan hydrobromide, bupropion hydrochlorideAxsome Therapeutics, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85807SUPPL 2026-05-12
85805SUPPL 2026-05-12
85818SUPPL 2026-05-06
85819SUPPL 2026-05-04
85806SUPPL 2026-05-01
84097SUPPL 2025-11-06
84096SUPPL 2025-11-06
84092SUPPL 2025-11-06
78921ORIG 2024-06-27
78431SUPPL 2024-05-08
78420SUPPL 2024-05-07
71853ORIG2022-08-19
71851ORIG2022-08-19
71849ORIG2022-08-19